SEHA, a subsidiary of PureHealth, the largest healthcare group in the Middle East, announced that SEHA’s Al Dhafra Family Medicine Centre has earned the American Heart Association’s (AHA) Hypertension Practice Centre Certification, recognising its structured, evidence-based approach to
AHA
Novo Nordisk today presented new results from the landmark POSEIDON real-world evidence study at the 94th European Atherosclerosis Society (EAS) Congress in Athens, Greece. The study showed that CV inflammation remains highly prevalent among people with CVD despite current standard-of-care treatment. The study found that 2 in 5 people with ASCVD and CKD had CV
According to the American Heart Association (AHA) and the World Health Organization (WHO), the Eastern Mediterranean Region (EMR), which includes most Middle East and North Africa (MENA) countries, is now among the regions with the highest prevalence of cardiovascular diseases (CVDs) globally, with a sharp rise attributed to preventable, lifestyle-related risk factors such












